Intertek Cantox offers solutions to help industry meet reporting
ONTARIO, Canada, Nov. 2, 2011 /CNW/ - Intertek Cantox, a leading
provider of scientific and regulatory consulting services, today
announced its delivery of new services to help the Food, Drug, and
Cosmetic industries take full advantage of Health Canada's invitation
to nominate existing ingredients to the Revised In-Commerce List
(ICL). This Revised ICL is expected to form the basis of exemptions
from the need to secure pre-market approval under the upcoming
Environmental Assessment Regulations. These Environmental Assessment
Regulations will trigger the need for independent approval of "new"
ingredients under the Canadian Environmental Protection Act in addition
to the current regulatory approval obligations under the Food and Drugs
Act. The Revised ICL will be the basis upon which substances are
deemed not "new."
"Canada is taking a unique regulatory approach for assessing and
managing the environmental and indirect human health impacts of
substances in products regulated under the Food and Drugs Act" states
Joyce Borkhoff, Director of Intertek Cantox's Chemicals Group. "In
order to protect their existing market shares, the FDA regulated
industries should pay close attention to Health Canada's initiative and
act quickly to secure the ICL's EAR exemption status."
The key to success in securing the ICL advantage will be a clear
understanding of product composition and ingredient identification.
ICL nomination is open to finite chemicals, polymers, complex mixtures,
botanicals, enzymes and micro-organisms that were in the Canadian
market place between 1987 and 2001. The nomination period is expected
to close February 2012 and non-resident stakeholders must submit their
nominations through a Canadian agent.
Intertek Cantox's specialized team of regulatory and scientific experts
located in Mississauga, Ontario, have been closely tracking Health
Canada's ICL initiatives and EAR developments since this government
interest was first announced in September of 1999. With this
experience, the team is well positioned and ready to immediately
deliver expert support to help companies protect the sustainability of
their product lines in Canada.
For more information on Intertek Cantox's Services, please visit: http://www.intertek.com/cantox. For further information on Intertek's portfolio of Health,
Environmental and Regulatory Services, please visit www.intertek.com/green.
Intertek is a leading provider of quality and safety solutions serving a
wide range of industries around the world. From auditing and
inspection, to testing, quality assurance and certification, Intertek
people are dedicated to adding value to customers' products and
processes, supporting their success in the global marketplace. Intertek
has the expertise, resources and global reach to support its customers
through its network of more than 1,000 laboratories and offices and
30,000 people in over 100 countries around the world. Intertek Group
plc (LSE: ITRK) is listed on the London Stock Exchange and is a
constituent of the FTSE 100 index.
Intertek Cantox is part of Intertek Health, Environmental and Regulatory
Services (www.intertek.com/green) which services cover an expansive range of specialized expertise in
the areas of Food & Nutrition, Pharmaceutical & Healthcare, Chemicals,
and Agriculture, Biotech & Consumer Products. For over 25 years,
Intertek Cantox' specialists have been helping companies resolve
complex scientific and toxicology issues, develop scientific and
strategic regulatory and compliance plans, and facilitate timely
regulatory global approvals. Intertek Cantox's professionals deliver
success and minimize client risk through the company's broad expertise
and knowledge of the regulatory approval processes that govern food,
drug, and cosmetic products in North America, Europe, and other
jurisdictions around the world. For more information, visit www.intertek.com/cantox.
SOURCE Intertek Cantox
For further information: